Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S272400
Reexamination Certificate
active
06875779
ABSTRACT:
The present invention relates to compounds of the formulawherein R1, R3, R5and A are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment of inflammation and other inflammation associated disorders, such as osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals (preferably humans, dogs, cats and livestock).
REFERENCES:
patent: 4259504 (1981-03-01), Lang, Jr. et al.
patent: 4962119 (1990-10-01), Boschelli et al.
patent: 5066668 (1991-11-01), Boschelli et al.
patent: 5376670 (1994-12-01), Connor et al.
patent: 0003895 (1979-02-01), None
patent: 0155486 (1985-02-01), None
patent: 1099695 (1999-09-01), None
patent: 1104760 (2000-11-01), None
patent: 937732 (1962-01-01), None
patent: WO9951580 (1999-10-01), None
Chaby (Drug Discovery Today 4(5) 209-221, May 1999.*
Opal et al. (Infectious Disease Clinics of North America 13(2), pp. 285-297, Jun. 1999.*
Tsuji, et al., “Studies on Anti-inflammatory Agents V. Synthesis and Pharmacological Properties of 3-(Diluoromethyl)-1-(4-methoxphenyl)-5-[4-(methylsulfinyl)phenyl]pyrazole and Related Compounds”,Chem Pharm Bull 45(9), pp. 1475-1481 (1997).
Tsuji, et al., “Studies on Anti-inflammatory Agents IV. Synthesis and Pharmacological Properties of 1,5-Diarylpyrazoles and Related Derivatives”,Chem. Pharm. Bull, 45(6), pp. 987-995 (1997).
Vane, et al., “Inducible Isoforms of Cyclooxygenase and Nitric-oxide Synthase in Inflammation”,Proc. Natl. Acad. Sci, 91, pp. 2046-2050 (1994).
Stanforth, “Catalytic Cross-coupling Reactions in Biaryl Synthesis”,Tetrahedron54, pp. 263-303 (1998).
Forrest, et al., “Chemotherapeutic Agents of Sulphone Type. Part V.2:5-Disubstituted Derivatives of Pyridine”,J. Chem Soc., pp. 1939-1945 (1945).
Cashin, et al., “The Pharmacology of Benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benoxazole Acetic Acid), LRCL 3794, a new Compound with Anti-inflammatory Activity Apparently Unrelated to Inhibition of Prostaglandin Synthesis”,J. Pharm. Pharmac.29, pp. 330-336 (1977).
Ezer, et al., “Antagonism of the Gastrointestinal Ulcerogenic Effect of Some Non-steroidal Anti-inflammatory Agents by Sodium Salicylate”,J. Pharm. Pharmac. 28, pp. 655-656 (1976).
Ricketts, et al., “Evaluation of Selective Inhibition of Canine Cyclooxygenase 1 and 2 by Carprofen and other Nonsteroidal and Anti-inflammatory Drugs”,AJVR59 (11). pp. 1441-1446 (1998).
Szilagyi, et al., “Preparation and Antiarthritic Activity of New 1,5-diaryl-3-alkylthio-1H-1,2,4-triazoles and Corresponding Sulfoxides and Sulfones”,Eur. J. Med. Chem25, pp. 95-101 (1990).
Hassaneen, et al. “A Convenient Synthesis of 3,5-Bipyrazolyl Derivatives Via Hydrazonyl Halides”,Hetercycles31 (6), pp. 1041-1046 (1990).
Brideau, et al., “A Human Whole Blood Assay for Clinical Evaluation of Biochemical Efficacy of Cyclooxygenase Inhibitors”,Inflamm Res, 45, pp. 68-74 (1996).
Moore, et al., “Teridap, a Structurally Novel Drug for the Treatment of Arthritis: Antiinflammatory and Analgesic Properties”,Inflamm. Res.45, pp. 54-61 (1996).
Lombardino, et al., “Acidic Antiinflammatory Agents—Correlations of Some Physical, Pharmacological and Clinical Data”,Arzneim, Forsch, 25(10), pp. 1629-1635 (1975).
Budesinisky, et al., “Nucleophilic Substitutions in the 2-methanesulfonylpyrimidine Series”,Collection Czechoslov, Chem. Commun.37, pp. 1721-1733, (1972).
Winter, et al., “Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs”,Proc. Soc. Exp. Biol. Med.111, pp. 544-547 (1962).
English Translation of European Patent Application No. 0 155 486.
Rast Bryson
Sakya Subas M.
Shavnya Andrei
Berch Mark L.
Habte Kahsay
Hosley Mary J.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3380591